606 results on '"Blome, C"'
Search Results
102. Subjektives Wohlbefinden als Maß des Patientennutzens: Validierung des 'Daily Experience Sampling Questionnaire' (DESQ)
103. Supply Chain Evolution – Theory, Concepts, Science
104. Characterizing treatment‐related patient needs in atopic eczema: insights for personalized goal orientation.
105. Validation of a short-form of the Freiburg Life Quality Assessment for lymphoedema (FLQA-LS) instrument
106. Validity Of Patient-Reported Outcomes From Columbus, A Randomized Open Label Phase Iii Clinical Trial Of Encorafenib Plus Binimetinib VS Vemurafenib In Advanced Braf-Mutant Melanoma
107. Observation of Structural Anisotropy and the Onset of Liquid-like Motion during the Non-thermal Melting of InSb
108. Erratum zu: Erfassung von Pruritus: aktuelle Standards und Implikationen für die Praxis: Konsensuspaper der Initiative Pruritusparameter der Arbeitsgemeinschaft Pruritusforschung (AGP)
109. Patient-reported outcome measures in pruritus: A systematic review of measurement properties
110. The dark side of global sourcing: a systematic literature review and research agenda
111. Using Vignettes to Detect Response Shift in Measuring Health-Related Quality of Life
112. Krankheitsspezifische Lebensqualität bei Patienten mit Beinulcera - Eine Übersicht zu Messinstrumenten und Ergebnissen
113. Accepted standards on how to give a Medical Research Presentation: a systematic review of expert opinion papers
114. The Dark Side of Buyer Power: Supplier Exploitation and the Role of Ethical Climates
115. P107 Treatment benefit of the 5-grass tablet in children: assessment from the patient's point of view
116. Efficacy of Body Lotion Containing N-palmitoylethanolamine in Subjects with Chronic Pruritus due to Dry Skin: A Dermatocosmetic Study
117. Quality of life assessment and use of patient-reported outcomes in practice
118. Dynamic Pruritus Score: Evaluation of the Validity and Reliability of a New Instrument to Assess the Course of Pruritus
119. Die Definition und Rolle von Lebensqualität im Rahmen der frühen Nutzenbewertung nach AMNOG
120. Methodische Anforderungen an Lebensqualitätsdaten in der frühen Nutzenbewertung von Arzneimitteln: eine qualitative Analyse
121. Patientenrelevante Therapieziele in der Psoriasisbehandlung
122. Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double-blind, controlled, pilot study in dry skin
123. Cross‐European validation of the ItchyQoL in pruritic dermatoses.
124. European EADV network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools
125. Supply chain evolution – theory, concepts and science
126. Sustainability in multi-tier supply chains: Understanding the double agency role of the first-tier supplier
127. Subjektives Wohlbefinden als patientenrelevanter Nutzen: Wie lassen sich Verzerrungen durch Response Shift quantifizieren?
128. Der 'Daily Experience Sampling Questionnaire' (DESQ): ein neuer Ansatz zur Messung des subjektiven Wohlbefindens
129. Entwicklung und Validierung von Instrumenten zur Erfassung der Lebensqualität und des Therapienutzens bei Patienten mit peripherer arterieller Verschlusskrankheit
130. European EADV network on assessment of severity and burden of Pruritus (PruNet):first meeting on outcome tools
131. Patient-relevant needs and treatment goals in nail psoriasis
132. Ultrafast structural dynamics in solids investigated with femtosecond x-ray pulses
133. Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis
134. Motives and Performance Outcomes of Sustainable Supply Chain Management Practices: A Multi-theoretical Perspective
135. Global sourcing decision-making processes: Politics, intuition, and procedural rationality
136. The performance impact of supply chain agility and supply chain adaptability: The moderating effect of product complexity
137. Messung des patientenrelevanten Nutzens bei rheumatoider Arthritis und multipler Sklerose
138. PCN172 - Validity Of Patient-Reported Outcomes From Columbus, A Randomized Open Label Phase Iii Clinical Trial Of Encorafenib Plus Binimetinib VS Vemurafenib In Advanced Braf-Mutant Melanoma
139. Entwicklung und Validierung des 'Patient Benefit Index 2.0' – ein Kurzfragebogen zur Erhebung des patientenrelevanten Therapienutzens in der Dermatologie
140. Lymphödeme – der lange Weg zu Diagnose und Behandlung
141. Assessment of pruritus - current standards and implications for clinical practice : consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)
142. Ergebnisse der Versorgungsstudie LEOS – Lymphödeme im Großraum Hamburg
143. Patient-relevant needs and treatment goals in nail psoriasis
144. European EADV network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools
145. Therapieziele und Therapienutzen bei dermatologischen Patienten
146. Frühe Nutzenbewertungen im dermatologischen Bereich
147. Die Messung des patientenrelevanten Nutzens in der Dermatologie
148. Differences in patient and physician assessment of a dynamic patient reported outcome tool for chronic pruritus
149. Antipruritische Effekte und individuelle Patientenbedürfnisse bei der topischen Therapie des chronischen Pruritus
150. Complementarity effect of governance mechanisms on environmental collaboration: Does it exist?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.